Flow Traders U.S.’s WisdomTree BioRevolution Fund WDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-16,344
| Closed | -$276K | – | 1328 |
|
|
2025
Q4 | $276K | Sell |
16,344
-9,838
| -38% | -$168K | 0.01% | 725 |
|
|
2025
Q3 | $416K | Buy |
26,182
+9,720
| +59% | +$140K | 0.02% | 660 |
|
|
2025
Q2 | $225K | Sell |
16,462
-10,470
| -39% | -$133K | 0.01% | 819 |
|
|
2025
Q1 | $346K | Buy |
+26,932
| New | +$385K | 0.01% | 690 |
|
|
2024
Q3 | – | Sell |
-11,823
| Closed | -$187K | – | 1177 |
|
|
2024
Q2 | $187K | Buy |
+11,823
| New | +$190K | 0.01% | 755 |
|
|
2024
Q1 | – | Sell |
-15,125
| Closed | -$255K | – | 1094 |
|
|
2023
Q4 | $255K | Sell |
15,125
-11,038
| -42% | -$167K | 0.01% | 633 |
|
|
2023
Q3 | $396K | Sell |
26,163
-1,554
| -6% | -$26.2K | 0.02% | 539 |
|
|
2023
Q2 | $483K | Buy |
27,717
+1,215
| +5% | +$21.1K | 0.02% | 511 |
|
|
2023
Q1 | $455K | Sell |
26,502
-67,198
| -72% | -$1.18M | 0.02% | 506 |
|
|
2022
Q4 | $1.63M | Buy |
93,700
+12,679
| +16% | +$225K | 0.08% | 216 |
|
|
2022
Q3 | $1.36M | Buy |
81,021
+16,080
| +25% | +$297K | 0.07% | 253 |
|
|
2022
Q2 | $1.13M | Buy |
64,941
+26,035
| +67% | +$471K | 0.06% | 302 |
|
|
2022
Q1 | $786K | Buy |
38,906
+5,767
| +17% | +$116K | 0.03% | 427 |
|
|
2021
Q4 | $783K | Buy |
33,139
+20,256
| +157% | +$498K | 0.04% | 345 |
|
|
2021
Q3 | $328K | Sell |
12,883
-19,544
| -60% | -$516K | 0.01% | 809 |
|
|
2021
Q2 | $866K | Buy |
+32,427
| New | +$848K | 0.04% | 434 |
|
Other funds holding WDNA
Flow Traders U.S.'s WDNA Position: Q1 2026 in Review
Flow Traders U.S. sold out of WisdomTree BioRevolution Fund (WDNA) in Q1 2026, closing a stake of 16,344 shares — an estimated $276K sold.
Flow Traders U.S. first reported a position in WDNA in Q2 2021 and held it in 16 quarters. The position peaked at $1.63M in Q4 2022. 3 funds tracked by Wall St. Rank hold WDNA as of Q1 2026.
- Flow Traders U.S. reported no remaining WisdomTree BioRevolution Fund position as of Q1 2026 after selling out during the quarter.
- Flow Traders U.S. sold 16,344 WisdomTree BioRevolution Fund shares in Q1 2026, an estimated $276K.
- Flow Traders U.S. first reported a position in WisdomTree BioRevolution Fund in Q2 2021 and held it in 16 quarters.
- Flow Traders U.S.'s WisdomTree BioRevolution Fund position peaked at $1.63M in Q4 2022.
- 3 funds tracked by Wall St. Rank held WisdomTree BioRevolution Fund as of Q1 2026.
Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.